Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838

This study has been completed.
Information provided by (Responsible Party):
Hoffmann-La Roche Identifier:
First received: May 18, 2011
Last updated: October 3, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)